5 月 8 泌尿外科和泌尿妇科 Three-Year Data from ROBUST III Confirms Long-Term Durability of Optilume® Drug-Coated Balloon for Recurrent Urethral Strictures Laborie Medical Technologies Corp. (Laborie), a global leader in diagnostic and … 阅读更多
1 月 17 泌尿外科和泌尿妇科 Optilume Drug-Coated Balloon Shows Long-Term Efficacy for Urethral Strictures: Five-Year Data Published in the Journal of Urology 阅读更多
10 月 28 未分类 | 泌尿外科和泌尿妇科 Optilume® BPH Catheter System Issued Category 1 CPT Code by American Medical Association 阅读更多
7 月 17 产科、妇科和新生儿科 Laborie Medical Technologies to Invest in Medical Technology Start-Up Novocuff Laborie announced its investment in Novocuff, an early-stage medical technology … 阅读更多
5 月 21 胃肠病科 Laborie Introduces Solar Compact System and Solar Anorectal Manometry Catheter for Enhanced Gastrointestinal Diagnostics Laborie is proud to introduce the Solar Compact System and Solar Anorectal Manom … 阅读更多
5 月 13 泌尿外科和泌尿妇科 Laborie Unveils Positive Study Results for Optilume® BPH Catheter System Laborie announced positive 2-year and 5-year results from studies for its Optilu … 阅读更多
4 月 30 泌尿外科和泌尿妇科 NHS England Reimburses Optilume® Urethral Drug Coated Balloon as Part of the Specialised Services Device Programme Laborie welcomed the inclusion of Optilume® Urethral Drug-Coated Balloon (DCB) i … 阅读更多
3 月 29 泌尿外科和泌尿妇科 Laborie Medical Technologies Invests in iO Urology and the CarePath Uroflow Device Laborie Medical Technologies announced a strategic equity investment in Bright … 阅读更多
1 月 8 胃肠病科 Laborie Introduces the Next Generation RenovaRP™Centesis System Announcing the launch of the RenovaRP™ Centesis System, an innovative fluid drai … 阅读更多
11 月 30 未分类 Laborie Medical Technologies Invests in Medical Technology Start-Up Bright Uro Laborie Medical Technologies announced a strategic equity investment in Bright … 阅读更多
